PTEN and neoplasm: Mice with PTEN-deficient myeloid cells exhibit decreased chemotherapy-induced NLRP3 activity in the tumour microenvironment and resistance to Mitoxantrone, suggesting that PTEN-induced NLRP3 activity promotes anti-tumour immunity and tumour suppression [32].